Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Sequencing » French Genome Profiling Trial Points to Frequent Actionable Mutations in Advanced Cancer

French Genome Profiling Trial Points to Frequent Actionable Mutations in Advanced Cancer

Jun 03, 2017
|
Andrea Anderson

CHICAGO (GenomeWeb) – Targeting actionable genetic mutations identified by tumor genomic profiling may slightly boost survival time in individuals with advanced cancer, though there are still challenges accessing molecularly tailored treatments for individuals with such mutations. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Suit and Settlement

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

CRUK Announces Cuts

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Long Wait

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

PNAS Papers on Ancient European Migrations, Triple-Negative Breast Cancer Fusions, More

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.

May
06
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In Sequencing

  1. With Sputum Test for SARS-CoV-2, MicroGen Dx Aims to Challenge Quest, LabCorp

  2. NanoString Preliminary Q1 Revenues Take Hit From COVID-19, Firm Withdraws 2020 Guidance

  3. The Decade in Genomics: CRISPR, Single Cells, Long Reads, Clinical and Consumer Applications

    Premium

  4. Multiomic Approach Measures Protein Expression, RNA Transcript Levels of Single Cells

  5. Blood-Based Genetic Risk Score Shows Promise for Prostate Cancer Drug Response, Survival Prediction

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.